Please use this identifier to cite or link to this item:
http://hdl.handle.net/10553/43041
Title: | Results of a model of secondary prevention for osteoporotic fracture coordinated by rheumatology and focused on the nurse and primary care physicians | Authors: | Naranjo, Antonio Ojeda-Bruno, Soledad Bilbao Cantarero, Ana Quevedo Abeledo, Juan Carlos Henríquez-Hernández, Luis Alberto Rodríguez-Lozano, Carlos |
Issue Date: | 2014 | Publisher: | 1699-258X | Journal: | Reumatologia Clinica | Abstract: | Objective: To assess the influence of the implementation of a program for secondary prevention of osteoporotic fractures on prescribing bisphosphonates and persistent short-term treatment. Patients and methods: Patients >. 50 years with fragility fracture attended in the emergency department were enrolled in an observational study. The program consisted of: 1) training of primary care physicians, 2) baseline visit: questionnaire on osteoporosis, bone densitometry and patient education, 3) patient referral to primary care, except those with multiple fractures or requiring special study or therapy, who were referred to a specialist, and 4) follow-up by checking prescriptions in electronic records, and a telephone survey. The outcome variable was the percentage of patients who, on having been prescribed bisphosphonates, still adhered to the treatment at 3 months. Results: Of the 532 patients with inclusion criteria, 202 (39%) refused to participate. Those who refused to take part had a higher mean age (P<. .01) and a higher frequency of hip fracture (P<. .01) compared with patients who did participate. A total of 330 patients were included for intervention, with a mean age of 71 years, and 254(77%) were female. An antiresorptive was being used by 45 patients (13%) at baseline. After the baseline visit 223 patients (67%) were recommended a bisphosphonate. In the follow-up at 3 months 78% of patients who had been prescribed bisphosphonate were still receiving treatment. Conclusions: We present a multidisciplinary program for secondary prevention of fractures coordinated by rheumatology in which the number of patients who were receiving bisphosphonate at 3 months increased by four times compared to baseline visit. © 2013 Elsevier España, S.L.U. | URI: | http://hdl.handle.net/10553/43041 | ISSN: | 1699-258X | DOI: | 10.1016/j.reuma.2013.12.007 | Source: | Reumatologia Clinica[ISSN 1699-258X],v. 10 (5), p. 299-303 |
Appears in Collections: | Artículos |
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.